WHO ICTRP trial
In vivo PET of synaptic density in cognitive disorders: prospective evaluation…
CTIS2024-514577-22-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-514577-22-00 |
|---|---|
| Public title | In vivo PET of synaptic density in cognitive disorders: prospective evaluation of neuronal dysfunction and relation to symptomatology. |
| Primary sponsor | UZ Leuven |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Belgium |
| Conditions | Cognitive Disorders including Alzheimer's Disease, Frontotemporal dementia, Lewy Body Disease and psychiatric disorders.;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01] |
| Registration date | Dec 6, 2024 |
| Target size | 150 |
| Secondary IDs | NCT05384353 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: